New York Psychiatrist, Dr. Aleksandra Krunic, Introduces Groundbreaking FDA-Cleared Helmet to Treat Obsessive-Compulsive Disorder (OCD)
07 août 2019 09h00 HE | Child and Adult Psychiatry of New York
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Dr. Aleksandra Krunic, head of Child and Adult Clinical Psychiatry New York, a top psychiatric clinic serving patients in Long Island and New York City...
Seelos_full logo and icon color.jpg
Seelos Therapeutics to Ring Opening Bell at Nasdaq on August 12th
06 août 2019 09h00 HE | Seelos Therapeutics, Inc.
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that Raj Mehra, PhD, Chairman, Founder, and CEO of...
Nexstim NBT® system
Nexstim NBT® system authorized for commercial distribution in Australia
05 août 2019 06h00 HE | Nexstim Oyj
Press release, Helsinki, 5 August 2019 at 1 pm (EET) Nexstim NBT® system authorized for commercial distribution in Australia Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") - the...
Seelos_full logo and icon color.jpg
Seelos Therapeutics Reports Q2 2019 Pipeline Update
01 août 2019 09h00 HE | Seelos Therapeutics, Inc.
NEW YORK, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, today released its second quarter pipeline update. “We have made...
emergo_logo_left-notagline.jpg
Susan Kenney Certified as a Brain Health Coach by Amen Clinics
30 juil. 2019 08h00 HE | Emergo Recovery
BARRIE, Ontario, July 30, 2019 (GLOBE NEWSWIRE) -- Susan Kenney, Co-Founder and Director of Therapeutic Wellness at Emergo Recovery, has been certified by Amen Clinics as a Brain Health Coach. The...
BransWay logo.jpg
Achieve TMS East Celebrates the Opening of its Haverhill Location
25 juil. 2019 09h00 HE | BrainsWay Ltd.
HAVERHILL, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, Massachusetts’ largest provider of deep TMS therapy for the treatment of Depression and OCD, is pleased to announce the opening...
Nexstim Abp: Ändring
Nexstim Abp: Ändring i sammansättningen av Nexstim Abp:s styrelseutskott
25 juil. 2019 07h00 HE | Nexstim Oyj
Pressmeddelande, Helsingfors 25 juli 2019, kl. 14.00 Nexstim Abp: Ändring i sammansättningen av Nexstim Abp:s styrelseutskott Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”), ett...
Nexstim Oyj: Muutos
Nexstim Oyj: Muutos hallituksen valiokuntien jäsenissä
25 juil. 2019 07h00 HE | Nexstim Oyj
Yhtiötiedote, Helsinki, 25.7.2019 klo 14.00 Nexstim Oyj: Muutos hallituksen valiokuntien jäsenissä Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”), neuromodulaatioyritys, joka on...
Nexstim Plc: Change
Nexstim Plc: Change in Members of the Board Committees
25 juil. 2019 07h00 HE | Nexstim Oyj
Company announcement, Helsinki, 25 July 2019 at 2.00 PM Nexstim Plc: Change in Members of the Board Committees Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted...
Fluoxetine Market Research Report By Size, Share, Type, Application and Top Players 2018-2026 | Reports And Data
24 juil. 2019 10h01 HE | Reports and Data
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Fluoxetine market is a thorough analysis of the size, share, demand, growth, gross profits, earnings, and revenue of the industry. It...